Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026

A05192
Pages: 212
Nov 2019 | 2262 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 121
Charts: 15
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Human Growth Hormone (hGH) Market

Request Now !

Human Growth Hormone (hGH) Market Overview:

The global human growth hormone market size was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. The human growth hormone also known as somatotropin is a peptide hormone secreted by the pituitary gland that regulates cell growth, cell regeneration & repair, reproduction, and metabolism contributing to the overall development of humans. The growth hormone levels in the human body should be optimum for normal growth and can be regulated by factors such as exercise, sleep, stress, and lower glucose levels. Human growth hormones also help in controlling body composition, muscle & bone growth, body fluids, sugar & fat metabolism, and recovery from injury. It also helps to boost muscle strength & performance. Moreover, lower or higher levels of growth hormone may affect the quality of life thereby, increasing the risks of diseases such as high cholesterol levels, growth hormone deficiency, or poor bone density. Lower levels of human growth hormone increase the risk of diseases and results in fat accumulation throughout the body, whereas higher levels of the same may cause gigantism in children and acromegaly, muscle-wasting disease, and short bowel syndrome in adults. The human growth hormone levels decrease with age. This natural slowdown in the production of growth hormones in human body has triggered the interest in using synthetic growth hormone therapies across the world.

Human Growth Hormone Market

Get more information on this report : Request Sample Pages

Rise in awareness regarding the effectiveness of growth hormones, demand for cost efficient growth hormone therapies; increase in prevalence of serious chronic diseases such as chronic kidney disease and growth retardation, and pituitary dysfunctions; and surge in compliance for growth hormone formulations are the major factors that drive the growth of the global human growth hormone market. For instance, incidence of isolated growth hormone deficiency is estimated to be 1 in 4,000 to 10,000 individuals worldwide. Further, growth hormone deficiency occurs in around 1 in 7,000 live births. However, the unfavorable effects such as muscle pain, joint pain, and fluid retention associated with the use of synthetic growth hormones and high cost involved in the treatments using these growth hormones hinder the growth of the HGH market. Moreover, stringent government approvals are expected to restrain the growth and development of the human growth hormone market in the coming years. On the contrary, rise in disposable income and surge in healthcare expenditure in developing economies is anticipated to create lucrative opportunities for the manufactures of growth hormones in the future.

The human growth hormone market can be segmented on the basis of application, route of administration, distribution channel, and region. By application, it is categorized into growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, small for gestational age, and others. By route of administration, it is classified into intravenous, intramuscular, subcutaneous, and oral. On the basis of distribution channel, it is divided into hospital pharmacy, retail pharmacy, clinic, and online pharmacy. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

Application segment review

By application, the Turner syndrome segment dominated the market in 2018, and is expected to exhibit a prominent growth rate in the future, owing to the surge in its incidence across the globe. For instance, according to the U.S. National Organization of Rare Disorders, it is estimated that more than 70,000 women and girls in the country have Turner syndrome.

Human Growth Hormone (hGH) Market
By Application

Your browser does not support the canvas element.

Growth Hormone Deficiency is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Route of administration segment review

By route of administration, the subcutaneous segment dominated the human growth hormone market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that growth hormones administered subcutaneously have more bioavailability compared to other routes of administration.

Human Growth Hormone (hGH) Market
By Route of Administration

Your browser does not support the canvas element.

Subcutaneous route of administration is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

North America accounted for majority of the human growth hormone market share in 2018, and is anticipated to continue this trend during the forecast period. This is attributed to the increased consumption of human growth hormone therapies in this region to treat various disorders such as Turner syndrome. Further ease of availability of artificial growth hormones and rise in R&D toward recombinant human growth hormone propel the market growth in this region. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the rise in incidence of growth hormone deficiency disorders in this region. Moreover, rise in healthcare expenditure, penetration of leading players, and surge in disposable income are the major factors that boost the human growth hormone market growth in this region.

Human Growth Hormone (hGH) Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 10.2% during 2019-2026.

Get more information on this report : Request Sample Pages

The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their regional presence through collaborations and partnerships and increase in investments to develop long-acting and effective products with lower adverse effects. Major players operating in the human growth hormone market include Novo Nordisk, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Novartis AG, AnkeBio Co. Ltd, F. Hoffmann-La Roche, Ipsen, and Ferring BV.

Key Benefits for Human Growth Hormone (hGH) Market:

  • The study of the human growth hormone market share is based on a comprehensive analysis of key developments in the human growth hormone industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the human growth hormone market trends to elucidate the imminent investment pockets.
  • The global human growth hormone market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global human growth hormone market forecast from 2019 to 2026 is provided to determine the market potential.

Human Growth Hormone (Hgh) Key Market Segments:

By Application

  • Growth Hormone Deficiency
  • Prader-Willi Syndrome
  • Turner Syndrome
  • Small for Gestational Age
  • Others

By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Pharmacy

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Research methodology

1.3.1.    Secondary research
1.3.2.    Primary research
1.3.3.    Analyst tools & models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Porter's five forces analysis
3.3.    Top player positioning
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Increase in usage of growth hormone to control aging
3.4.1.2.    Surge in disorders related to growth hormone deficiency

3.4.2.    Restraints

3.4.2.1.    Side effects associated with the treatment

3.4.3.    Opportunities

3.4.3.1.    Rise in awareness towards usage of human growth in developing economies

CHAPTER 4:    HUMAN GROWTH HORMONE MARKET, BY APPLICATION

4.1.    Overview

4.1.1.    Market size and forecast, by application

4.2.    Growth Hormone Deficiency

4.2.1.    Key market trends and opportunities
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis, by country

4.3.    Prader-Willi syndrome

4.3.1.    Key market trends and opportunities
4.3.2.    Market size and forecast, by region
4.3.3.    Market analysis, by country

4.4.    Turner Syndrome

4.4.1.    Key market trends and opportunities
4.4.2.    Market size and forecast, by region
4.4.3.    Market analysis, by country

4.5.    Small for Gestational Age (SGA)

4.5.1.    Key market trends and opportunities
4.5.2.    Market size and forecast, by region
4.5.3.    Market analysis, by country

4.6.    Others

4.6.1.    Key market trends and opportunities
4.6.2.    Market size and forecast, by region
4.6.3.    Market analysis, by country

CHAPTER 5:    HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION

5.1.    Overview

5.1.1.    Market size and forecast, by application

5.2.    Oral

5.2.1.    Market size and forecast, by region
5.2.2.    Market analysis, by country

5.3.    Intravenous

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis, by country

5.4.    Intramuscular

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis, by country

5.5.    Subcutaneous

5.5.1.    Market size and forecast, by region
5.5.2.    Market analysis, by country

CHAPTER 6:    HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL

6.1.    Overview

6.1.1.    Market size and forecast, distribution channel

6.2.    Hospital pharmacy

6.2.1.    Market size and forecast, by region
6.2.2.    Market analysis, by country

6.3.    Retail pharmacy

6.3.1.    Market size and forecast, by region
6.3.2.    Market analysis, by country

6.4.    Online pharmacy

6.4.1.    Market size and forecast, by region
6.4.2.    Market analysis, by country

CHAPTER 7:    HUMAN GROWTH HORMONE MARKET, BY REGION

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    North America

7.2.1.    Key market trends and opportunities
7.2.2.    Market size and forecast, by application
7.2.3.    Market size and forecast, by route of administration

7.2.4.    Market size and forecast, distribution channel

7.2.4.1.    U.S. market size and forecast, by application
7.2.4.2.    U.S. market size and forecast, by route of administration
7.2.4.3.    U.S. market size and forecast, distribution channel
7.2.4.4.    Canada market size and forecast, by application
7.2.4.5.    Canada market size and forecast, by route of administration
7.2.4.6.    Canada market size and forecast, distribution channel
7.2.4.7.    Mexico market size and forecast, by application
7.2.4.8.    Mexico market size and forecast, by route of administration
7.2.4.9.    Mexico market size and forecast, distribution channel

7.3.    Europe

7.3.1.    Key market trends and opportunities
7.3.2.    Europe market size and forecast, by application
7.3.3.    Europe market size and forecast, by route of administration
7.3.4.    Europe market size and forecast, distribution channel
7.3.5.    Europe market size and forecast, by country

7.3.5.1.    France market size and forecast, by application
7.3.5.2.    France market size and forecast, by route of administration
7.3.5.3.    France market size and forecast, distribution channel
7.3.5.4.    UK market size and forecast, by application
7.3.5.5.    UK market size and forecast, by route of administration
7.3.5.6.    UK market size and forecast, distribution channel
7.3.5.7.    Germany market size and forecast, by application
7.3.5.8.    Germany market size and forecast, by route of administration
7.3.5.9.    Germany market size and forecast, distribution channel
7.3.5.10.    Spain market size and forecast, by application
7.3.5.11.    Spain market size and forecast, by route of administration
7.3.5.12.    Spain market size and forecast, distribution channel
7.3.5.13.    Rest of Europe market size and forecast, by application
7.3.5.14.    Rest of Europe market size and forecast, by route of administration
7.3.5.15.    Rest of Europe market size and forecast, distribution channel

7.4.    Asia-Pacific

7.4.1.    Key market trends and opportunities
7.4.2.    Asia-Pacific market size and forecast, by application
7.4.3.    Asia-Pacific market size and forecast, by route of administration
7.4.4.    Asia-Pacific market size and forecast, distribution channel
7.4.5.    Asia-Pacific market size and forecast, by country

7.4.5.1.    Japan market size and forecast, by application
7.4.5.2.    Japan market size and forecast, by route of administration
7.4.5.3.    Japan market size and forecast, distribution channel
7.4.5.4.    China market size and forecast, by application
7.4.5.5.    China market size and forecast, by route of administration
7.4.5.6.    China market size and forecast, distribution channel
7.4.5.7.    India market size and forecast, by application
7.4.5.8.    India market size and forecast, by route of administration
7.4.5.9.    India market size and forecast, distribution channel
7.4.5.10.    Australia market size and forecast, by application
7.4.5.11.    Australia market size and forecast, by application
7.4.5.12.    Australia market size and forecast, distribution channel
7.4.5.13.    Rest of Asia-Pacific market size and forecast, by application
7.4.5.14.    Rest of Asia-Pacific market size and forecast, by route of administration
7.4.5.15.    Rest of Asia-Pacific market size and forecast, distribution channel

7.5.    LAMEA

7.5.1.    Key market trends and opportunities
7.5.2.    LAMEA market size and forecast, by application
7.5.3.    LAMEA market size and forecast, by route of administration
7.5.4.    LAMEA market size and forecast, distribution channel
7.5.5.    LAMEA market size and forecast, by country

7.5.5.1.    Brazil market size and forecast, by application
7.5.5.2.    Brazil market size and forecast, by route of administration
7.5.5.3.    Brazil market size and forecast, distribution channel
7.5.5.4.    Saudi Arabia market size and forecast, by application
7.5.5.5.    Saudi Arabia market size and forecast, by route of administration
7.5.5.6.    Saudi Arabia market size and forecast, distribution channel
7.5.5.7.    South Africa market size and forecast, by application
7.5.5.8.    South Africa market size and forecast, by route of administration
7.5.5.9.    South Africa market size and forecast, distribution channel
7.5.5.11.    Rest of LAMEA market size and forecast, by application
7.5.5.12.    Rest of LAMEA market size and forecast, by route of administration
7.5.5.13.    Rest of LAMEA market size and forecast, distribution channel

CHAPTER 8:    COMPANY PROFILES

8.1.    Novo Nordisk

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Operating business segments
8.1.4.    Product portfolio
8.1.5.    Business performance

8.2.    Merck & Co.

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product portfolio
8.2.5.    Business performance

8.3.    Eli Lilly And Company.

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio
8.3.5.    Business performance

8.4.    Pfizer Inc.

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product portfolio
8.4.5.    Business performance

8.5.    TEVA PHARMACEUTICAL INDUSTRIES.

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Product portfolio
8.5.5.    Business performance

8.6.    Novartis AG

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product portfolio
8.6.5.    Business performance

8.7.    Anhui Anke Biotechnology (Group) Co., Ltd.

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Product portfolio

8.8.    Roche

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product portfolio
8.8.5.    Business performance

8.9.    Ipsen

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product portfolio
8.9.5.    Business performance

8.10.    Ferring BV

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product portfolio
8.10.5.    Business performance

LIST OF TABLES

TABLE 01.    GLOBAL HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 02.    GROWTH HORMONE DEFICIENCY MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR GROWTH HORMONE DEFICIENCY, BY COUNTRY, 2018 & 2026 (%)
TABLE 04.    PRADER-WILLI SYNDROME MARKET BY REGION 2018–2026 ($MILLION)
TABLE 05.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR PRADER WILLI, BY COUNTRY, 2018 & 2026 (%)
TABLE 06.    TURNER SYNDROME MARKET BY REGION 2018–2026 ($MILLION)
TABLE 07.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR TURNER SYNDROME, BY COUNTRY, 2018 & 2026 (%)
TABLE 08.    HUMAN GROWTH HORMONE MARKET FOR SMALL FOR GESTATIONAL AGE (SGA) MARKET BY REGION 2018–2026 ($MILLION)
TABLE 09.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR SGH, BY COUNTRY, 2018 & 2026 (%)
TABLE 10.    HUMAN GROWTH HORMONE MARKET FOR OTHER APPLICATIONS BY REGION 2018–2026 ($MILLION)
TABLE 11.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018 & 2026 (%)
TABLE 12.    GLOBAL HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 13.    ORAL ROUTE OF ADMINSTRATION BY REGION, 2018–2026 ($MILLION)
TABLE 14.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR ORAL, BY COUNTRY, 2018 & 2026 (%)
TABLE 15.    INTRAVENOUS ROUTE OF ADMINISTRATION MARKET BY REGION 2018–2026 ($MILLION)
TABLE 16.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR INTRAVENOUS, BY COUNTRY, 2018 & 2026 (%)
TABLE 17.    INTRAMUSCULAR ROUTE OF ADMINISTRATION MARKET BY REGION 2018–2026 ($MILLION)
TABLE 18.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR INTRAMUSCULAR, BY COUNTRY, 2018 & 2026 (%)
TABLE 19.    SUBCUTANEOUS ROUTE OF ADMINISTRATION MARKET BY REGION 2018–2026 ($MILLION)
TABLE 20.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR SUBCUTANEOUS, BY COUNTRY, 2018 & 2026 (%)
TABLE 21.    GLOBAL HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 22.    HOSPITAL PHARMACY HUMAN GROWTH HORMONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 23.    RETAIL PHARMACY HUMAN GROWTH HORMONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 24.    ONLINE PHARMACY HUMAN GROWTH HORMONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 25.    HUMAN GROWTH HORMONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 26.    NORTH AMERICA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 27.    NORTH AMERICA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 28.    NORTH AMERICA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 29.    U.S. HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 30.    U.S. HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 31.    U.S. HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 32.    CANADA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 33.    CANADA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 34.    CANADA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 35.    MEXICO HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 36.    MEXICO HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 37.    MEXICO HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 38.    EUROPE HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39.    EUROPE HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 40.    EUROPE HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 41.    EUROPE HUMAN GROWTH HORMONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 42.    FRANCE HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 43.    FRANCE HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 44.    FRANCE HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 45.    UK HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 46.    UK HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 47.    UK HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 48.    GERMANY HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 49.    GERMANY HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 50.    GERMANY HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 51.    SPAIN HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 52.    SPAIN HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 53.    SPAIN HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 54.    REST OF EUROPE HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 55.    REST OF EUROPE HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 56.    REST OF EUROPE HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 57.    ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 58.    ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, BY ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 59.    ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 60.    ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 61.    JAPAN HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 62.    JAPAN HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 63.    JAPAN HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 64.    CHINA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 65.    CHINA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 66.    CHINA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 67.    INDIA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 68.    INDIA HUMAN GROWTH HORMONE MARKET, BY ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 69.    INDIA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 70.    AUSTRALIA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 71.    AUSTRALIA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 72.    AUSTRALIA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 73.    REST OF ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 74.    REST OF ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 75.    REST OF ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 76.    LAMEA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 77.    LAMEA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 78.    LAMEA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 79.    LAMEA HUMAN GROWTH HORMONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 80.    BRAZIL HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 81.    BRAZIL HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 82.    BRAZIL HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 83.    SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 84.    SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 85.    SAUDI ARABIA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 86.    SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 87.    SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 88.    SOUTH AFRICA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 89.    REST OF LAMEA HUMAN GROWTH HORMONE MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 90.    REST OF LAMEA HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2018–2026 ($MILLION)
TABLE 91.    REST OF LAMEA HUMAN GROWTH HORMONE MARKET, DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 92.    NOVO NORDISK: COMPANY SNAPSHOT
TABLE 93.    NOVO NORDISK: OPERATING SEGMENTS
TABLE 94.    NOVO NORDISK PLC: PRODUCT PORTFOLIO
TABLE 95.    MERCK & CO.: COMPANY SNAPSHOT
TABLE 96.    MERCK & CO. INC.: OPERATING SEGMENTS
TABLE 97.    MERCK & CO. INC.: PRODUCT PORTFOLIO
TABLE 98.    ELI LILLY AND COMPANY.: COMPANY SNAPSHOT
TABLE 99.    ELI LILLY AND COMPANY.: OPERATING SEGMENTS
TABLE 100.    ELI LILLY AND COMPANY.: PRODUCT PORTFOLIO:
TABLE 101.    PFIZER INC.: COMPANY SNAPSHOT
TABLE 102.    PFIZER INC.: OPERATING SEGMENTS
TABLE 103.    PFIZER INC.: PRODUCT PORTFOLIO
TABLE 104.    TEVA PHARMACEUTICAL INDUSTRIES.: COMPANY SNAPSHOT
TABLE 105.    TEVA PHARMACEUTICAL INDUSTRIES.: OPERATING SEGMENTS
TABLE 106.    TEVA PHARMACEUTICAL INDUSTRIES.: PRODUCT PORTFOLIO
TABLE 107.    NOVARTIS AG: COMPANY SNAPSHOT
TABLE 108.    NOVARTIS AG: OPERATING SEGMENTS
TABLE 109.    NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 110.    ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.: COMPANY SNAPSHOT
TABLE 111.    ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.: OPERATING SEGMENTS
TABLE 112.    ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD: PRODUCT PORTFOLIO
TABLE 113.    ROCHE: COMPANY SNAPSHOT
TABLE 114.    ROCHE: OPERATING SEGMENTS
TABLE 115.    ROCHE: PRODUCT PORTFOLIO
TABLE 116.    IPSEN: COMPANY SNAPSHOT
TABLE 117.    IPSEN: PRODUCT SEGMENTS
TABLE 118.    IPSEN: PRODUCT PORTFOLIO
TABLE 119.    FERRING BV.: COMPANY SNAPSHOT
TABLE 120.    FERRING BV.: OPERATING SEGMENTS
TABLE 121.    FERRING BV: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    GLOBAL HUMAN GROWTH HORMONE MARKET SEGMENTATION
FIGURE 02.    LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03.    MODERATE BARGAINING POWER OF BUYER
FIGURE 04.    MODERATE THREAT OF SUBSTITUTES
FIGURE 05.    LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.    LOW COMPETITIVE RIVALARY
FIGURE 07.    TOP PLAYER POSITIONING, 2018
FIGURE 08.    DRIVERS AND RESTRAINTS
FIGURE 09.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET, FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR RETAIL PHARMACY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.    COMPARATIVE SHARE ANALYSIS OF HUMAN GROWTH HORMONE MARKET FOR ONLINE PHARMACY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.    NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 13.    NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 14.    MERCK & CO.: NET SALES, 2016–2018 ($MILLION)
FIGURE 15.    MERCK & CO.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16.    MERCK & CO.: REVENUE SHARE BY REGION, 2018(%)
FIGURE 17.    ELI LILLY AND COMPANY: NET SALES, 2016–2018 ($MILLION)
FIGURE 18.    ELI LILLY AND COMPANY: REVENUE SHARE BY REGION, 2018(%)
FIGURE 19.    ELI LILLY AND COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 20.    PFIZER: NET SALES, 2016–2018 ($MILLION)
FIGURE 21.    PFIZER.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 01.    PFIZER INC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 02.    TEVA PHARMACEUTICAL INDUSTRIES.: NET SALES, 2016–2018 ($MILLION)
FIGURE 03.    TEVA PHARMACEUTICAL INDUSTRIES.: REVENUE SHARE BY REGIONS, 2018 (%)
FIGURE 04.    NOVARTIS AG: NET SALES, 2016–2018 ($MILLION)
FIGURE 05.    NOVARTIS AG: REVENUE SHARE BY REGION, 2018(%)
FIGURE 06.    NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 07.    ROCHE: NET SALES, 2016–2018 ($MILLION)
FIGURE 08.    ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 09.    ROCHE: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 10.    IPSEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 11.    IPSEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 12.    IPSEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 13.    FERRING BV.: NET SALES, 2016–2018 ($MILLION)
FIGURE 14.    FERRING BV.: REVENUE SHARE BY REGION, 2018(%)
FIGURE 15.    ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)

 
 

Human growth hormone (hGH) is a proteohormone secreted by the pituitary gland. It is mainly known to promote longitudinal growth in adolescents and effects various other metabolic functions throughout adult life such as enhancing protein production, promoting the utilization of fat, interfering with the action of insulin, and raising blood sugar levels. In addition, it also raises levels of insulin-like growth factor-1 (IGF-1).

The human growth hormone market is anticipated to witness a fast growth in the future, owing to rise in awareness among individuals toward use of artificial human growth hormones. It is increasingly being used to treat growth retardation in children. In addition, artificial human growth hormones are gaining traction among adults to get larger muscles, and improved exercise capacity from replacement therapy. However, the use of human growth hormone also encounters side effects among consumers such as fluid retention, joint and muscle pain, carpal tunnel syndrome (pressure on the nerve in the wrist causing hand pain and numbness), and high blood sugar levels. Thereby, side effects associated with these hormone consumptions are anticipated to hamper the market growth in the future. On the contrary, growth hormones are widely consumed by athletes in the U.S. to build their muscles and enhance performance. Significant increase in growth hormone consumption in the developing nations is expected to create lucrative opportunities in the near future for the manufacturers.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Human Growth Hormone (hGH) Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts